Tic

Sep 11, 2019

The global Tourette's syndrome drugs market at a CAGR of almost 5% during the forecast period

May 06, 2019

New AAN Guideline for Treating Tourette Syndrome and Other Chronic Tic Disorders

Apr 12, 2019

10 Questions Is All It Now Takes to Recognize Obsessive-Compulsive Disorder

Nov 12, 2018

Scientist recognized for dystonia research by The Michael J. Fox Foundation

Aug 14, 2018

Emalex Biosciences Acquires Psyadon Pharmaceuticals to Develop Novel Treatment for Pediatric Tourette Syndrome

Apr 09, 2018

Therapix Biosciences Announces Topline Results of Phase IIa Study at Yale University for Tourette Syndrome Program

Feb 07, 2018

Therapix Biosciences Completes Pre-IND Communication With FDA on THX-110 for Tourette Syndrome: Clinical Development to Proceed as Projected

Nov 28, 2017

Abide Therapeutics Reports Positive Topline Data from Phase 1b Study of ABX-1431 in Tourette Syndrome

Oct 23, 2017

Neurocrine Granted FDA Orphan Drug Designation for Valbenazine for the Treatment of Pediatric Patients With Tourette Syndrome